Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Apr 25, 2021
Date Accepted: Feb 19, 2022
Date Submitted to PubMed: Mar 15, 2022

The final, peer-reviewed published version of this preprint can be found here:

RWD-Cockpit: Application for Quality Assessment of Real-world Data

Babrak LM, Smakaj E, Agac T, Asprion PM, Grimberg F, der Werf DV, van Ginkel EW, Tosoni DD, Clay I, Degen M, Brodbeck D, Natali E, Schkommodau E, Miho E

RWD-Cockpit: Application for Quality Assessment of Real-world Data

JMIR Form Res 2022;6(10):e29920

DOI: 10.2196/29920

PMID: 35266872

PMCID: 9627468

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

RWD-Cockpit: Application for Quality Assessment of Real-World Data

  • Lmar Marie Babrak; 
  • Erand Smakaj; 
  • Teyfik Agac; 
  • Petra Maria Asprion; 
  • Frank Grimberg; 
  • Daan Van der Werf; 
  • Erris Willem van Ginkel; 
  • Deniz David Tosoni; 
  • Ieuan Clay; 
  • Markus Degen; 
  • Dominique Brodbeck; 
  • Eriberto Natali; 
  • Erik Schkommodau; 
  • Enkelejda Miho

ABSTRACT

Background:

Digital technologies are transforming the healthcare system. A large part of the digital information generated is data collected in uncontrolled settings, so-called real-world data (RWD). Data from electronic health records and digital biomarkers have the potential to reveal associations between the benefits and adverse events of medicines, establish new patient stratification principles, expose unknown disease correlations, and inform on preventive measures. The impact for healthcare payors and providers, the biopharmaceutical industry and governments, is massive in terms of health outcomes, quality of care and cost.

Objective:

However, a framework to assess the integrity and quality of RWD is missing, thus hindering the conduct of population-based observational studies to support regulatory decision-making and real-world evidence (RWE). We aim to build a framework that assesses the quality of RWD.

Methods:

We built the RWD-Cockpit web application (http://rwd.aihealth.ch/) which systematically scores datasets based on standard quality metrics and customizable variables chosen by the user.

Results:

Sleep real-world data were generated and used to validate the usability and applicability of the RWD cockpit web application.

Conclusions:

The output scores, Quality Identifiers (QI), provide the first quality assessment and validation for the use of RWD in regulated settings.


 Citation

Please cite as:

Babrak LM, Smakaj E, Agac T, Asprion PM, Grimberg F, der Werf DV, van Ginkel EW, Tosoni DD, Clay I, Degen M, Brodbeck D, Natali E, Schkommodau E, Miho E

RWD-Cockpit: Application for Quality Assessment of Real-world Data

JMIR Form Res 2022;6(10):e29920

DOI: 10.2196/29920

PMID: 35266872

PMCID: 9627468

Per the author's request the PDF is not available.